-
Experience of Pediatric Dental Screening in Hungary and in National Minority Groups in Romania
Sep 9, 2025, 16:22 PM -
Understanding the Impact of the NICE Severity Modifier: A Targeted Review of Oncology Submissions
Sep 9, 2025, 16:22 PM -
Real-World Evidence on the Broader Benefits of GLP-1RA-Based Therapies: A Global Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Price-Volume Regulation in France: Alignment Between Negotiated Thresholds With the French Economic Committee for Health Products (CEPS) and Real-World Observations
Sep 9, 2025, 16:22 PM -
Evolution of National Price Negotiations for Pharmacy/Retail Medicines (Triparty Negotiations) in Sweden and Implications for Access
Sep 9, 2025, 16:22 PM -
Impact of Individualized Neoantigen Therapies on Health, Productivity, and Health System Capacity Outcomes in Resected Melanoma in Belgium
Sep 9, 2025, 16:22 PM -
Economic Burden of COPD in Algeria: A Retrospective Analysis of Healthcare Resource Utilization and Costs
Sep 9, 2025, 16:22 PM -
Decluttering Complexity: A Pragmatic Framework for Simplifying Global Health Economic Models for HTA
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole for the Treatment of Invasive Aspergillosis in Morocco
Sep 9, 2025, 16:22 PM -
The Incidence, Mortality, and Survival of Nonmetastatic Colorectal Cancer (CRC) per TNM Stages in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2018-2022 Database Analysis
Sep 9, 2025, 16:22 PM -
Economic Evaluations of Medical Interventions for Adult People Living With Obesity: Protocol for a Systematic Literature Review
Sep 9, 2025, 16:22 PM -
NICE Has Embraced Single-Arm Trials in Technology Appraisals but Where Is the Guidance?
Sep 9, 2025, 16:22 PM -
Cost-Consequence Analysis of Transjugular Intrahepatic Portosystemic Shunt (TIPS) Treatment vs. Large-Volume Paracentesis (LVP) in the Management of Refractory Ascites: Preliminary Results Overview From an Italian Healthcare Perspective
Sep 9, 2025, 16:22 PM -
Country-Related Differential Item Functioning in the EQ-5D-5L: Insights From the EuroQol Data Assessment of Population Health Needs and Instrument Evaluation (EQ-DAPHNIE)
Sep 9, 2025, 16:22 PM -
Cost of Adverse Events With the Bruton Tyrosine Kinase Inhibitors Ibrutinib and Acalabrutinib in the First-Line Treatment of Chronic Lymphocytic Leukemia in Brazil
Sep 9, 2025, 16:22 PM -
Association Between Invasive Disease-Free Survival/Distant Recurrence-Free Survival and Overall Survival in Patients With Early Stage Triple-Negative Breast Cancer
Sep 9, 2025, 16:22 PM -
Flexible Parametric Inference for Cause-Specific Hazard-Competing Risk Models Under Interval Censoring
Sep 9, 2025, 16:22 PM -
From French Early Access to Regular Reimbursement: How Do Prices Shift Post-HTA?
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Early Scientific Advice Mechanisms: EU JSC vs. National HTA Bodies (HAS, G-BA, NICE)
Sep 9, 2025, 16:22 PM -
Survival Model Uncertainty in Economic Modeling: Evaluating Bootstrap and Cholesky Decomposition Methods
Sep 9, 2025, 16:22 PM
